Walpar Nutritions (NSE:WALPAR) Beta: -0.4340 (As of Jun. 29, 2026)


NSE:WALPAR Walpar Nutritions Ltd NSE:WALPAR
54 GF Score
Price ₹25.25
View Full Analysis

What is Walpar Nutritions Beta?

Walpar Nutritions NSE:WALPAR +4.99% 54 Beta is -0.4340 as of Jun. 29, 2026. GuruFocus rates NSE:WALPAR with a GF Score™ of 54/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Walpar Nutritions's Beta is -0.4340.


Walpar Nutritions  (NSE:WALPAR) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Walpar Nutritions Beta Related Terms


Walpar Nutritions Beta Historical Data

* Premium members only.

The historical data trend for Walpar Nutritions's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walpar Nutritions Beta Chart

Walpar Nutritions Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Walpar Nutritions Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:WALPAR vs ZTS, VTRS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Walpar Nutritions's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walpar Nutritions Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walpar Nutritions's Beta distribution charts can be found below:

* The bar in red indicates where Walpar Nutritions's Beta falls into.


NSE:WALPAR
54GF Score
Walpar Nutritions Ltd NSE:WALPAR
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Walpar Nutritions Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.4340 mean?
Walpar Nutritions (NSE:WALPAR) has a Beta of -0.4340 as of Jun. 29, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Walpar Nutritions and its competitors.
Is Walpar Nutritions' Beta too high?
Walpar Nutritions' current Beta is -0.4340. Overall, Walpar Nutritions has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Walpar Nutritions' Beta compare to ZTS and VTRS?
Walpar Nutritions' Beta of -0.4340 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Walpar Nutritions and its competitors. Walpar Nutritions's current Beta is -0.4340. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walpar Nutritions stock overvalued right now?
Walpar Nutritions (NSE:WALPAR) has a current Beta of -0.4340. The current Beta is -0.4340. Walpar Nutritions' overall GF Score™ is 54/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Walpar Nutritions (NSE:WALPAR), the current Beta is -0.4340 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Walpar Nutritions Business Description

Address Khatraj, 2nd Floor L5:377 Plot No 5, Omkar Estate, Opposite Sabarmati Gas Station, Kalol, Gandhinagar, GJ, IND, 382721
Walpar Nutritions Ltd is India-based company, which is engaged in manufacturing and trading of pharmaceutical, nutraceutical, herbal and ayurvedic commodities. It also manufactures various private label/third party brands for different companies across the country and overseas, as well as for their own brand sales. It is a manufacturer of various types of nutraceutical formulation, pharmaceutical ingredients, and pharmaceutical formulations. It specializes in contract manufacturing, raw materials trading, and direct selling. Its portfolio consists of tablets, capsules, powder/sachets, and oral liquids.
54GF Score

Get the complete analysis for NSE:WALPAR

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.25
Price